Langholzfeld, Austria

Karl-Heinz Giselbrecht

This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Rigel Pharmaceuticals, Incorporated, Patheon Austria Gmbh & Co. Kg. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl-Heinz Giselbrecht. Retrieved from https://idiyas.com/inventor/karl-heinz-giselbrecht-pj50cm48

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Langholzfeld, AT (2012 - 2014)
  • Linz, AT (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Karl-Heinz Giselbrecht

Introduction

Karl-Heinz Giselbrecht, an accomplished inventor from Langholzfeld, Austria, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, he has demonstrated remarkable ingenuity and expertise in his area of specialization.

Latest Patents

Among his latest innovations, Giselbrecht has developed methods for the synthesis of 2,4-pyrimidinediamines. These patents disclose valuable techniques for creating these compounds, along with the intermediates used in their synthesis. His work in this area is considered critical in advancing medicinal chemistry.

Career Highlights

Karl-Heinz Giselbrecht is currently associated with Rigel Pharmaceuticals, Incorporated, where he leverages his skills and experience to drive innovative projects forward. His dedication to developing new pharmaceutical solutions showcases his commitment to improving healthcare outcomes.

Collaborations

In his professional journey, Giselbrecht has collaborated with talented colleagues such as Michael Wolberg and Ulfried Felfer. These collaborations have fostered an environment of innovation and creativity, allowing them to explore and develop cutting-edge solutions in the pharmaceutical space.

Conclusion

In summary, Karl-Heinz Giselbrecht stands out as a notable inventor in the field of pharmaceuticals. With a strong portfolio of patents and a commitment to collaboration, his contributions continue to have a profound impact on research and development in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…